OraSure Technologies, Inc.
OraSure Technologies, Inc. and its affiliates are a global leader in the development, production, and commercialization of advanced oral fluid diagnostic solutions and specialized specimen collection tools, serving markets across the United States, Europe, and other international regions. The company operates through…
1D
-5.2%
1W
-7.4%
1M
+3.7%
6M
+14.2%
YTD
+49.2%
1Y
+18.0%
2Y
-11.3%
5Y
-65.7%
10Y
-53.8%
Next earnings date
04/11/2026 (in 18 days)
Volatility around earnings
~59% stronger price swings than usual
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Register for free
Unlock all 11 scores
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 03/08/2026.
PRICE TARGET LOW
US$4.00
CONSENSUS
US$4.00
MEDIAN
US$4.00
PRICE TARGET HIGH
US$4.00
0
STRONG BUY
4
BUY
9
HOLD
0
SELL
0
STRONG SELL
13
TOTAL · Hold
As of: 12/11/2025
P/E
-5.23
P/B
0.78
EV/EBITDA
-2.4
RETURN ON EQUITY
2.0%
NET MARGIN
20.4%
DEBT/EQUITY
0.04
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
82.6%
FLOAT SHARES
56,943,257
AVG. DAILY VOLUME (30D)
586,771
Boyd Steven Kyle
Kenny John P.
Boyd Steven Kyle
Kenny John P.
Marmora Lelio
OraSure Technologies, Inc. is a company in the Healthcare sector, Medical - Instruments & Supplies industry, headquartered in United States.
The CEO is Carrie Eglinton Manner, the company employs around 500 people.
The IPO was on 17/11/1986; the stock trades on NASDAQ under the ticker OSUR.
13 analysts rate the stock, the consensus is Hold (as of 12/11/2025).
The average price target is US$4.00, ranging from US$4.00 to US$4.00, with a median of US$4.00.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 04/11/2026.
Around past earnings, price swings were roughly 59% stronger than usual.
Yes. The last dividend was US$1.60 per share.
The dividend yield is 0.0% (as of 30/06/2026).
Comparable stocks include Intuitive Surgical, Becton, Dickinson and Company, ResMed, West Pharmaceutical Services, Solventum, Baxter International, Cooper Companies and Avantor.
Clicking "Analyze stock" lets five strategies assess OraSure Technologies against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.